Cryptographic controls matter because they let devices prove who they are, protect data in transit and at rest, and ensure only trusted software can run. In a healthcare environment, that reduces the chance that an illegitimate device, tampered update, or exposed data stream can be used to compromise patient-facing systems or device integrity.
What cryptography is doing inside a connected medical device
Cryptographic controls give a connected device a way to establish trust before it exchanges data or accepts commands. That means the device can authenticate itself, protect telemetry and clinical data, and verify that firmware or configuration updates have not been altered in transit. In practice, cryptography turns a networked device from “reachable” into “verifiably trusted.”
That matters because connected medical device are rarely isolated. They sit in clinical networks, integrate with gateways and management platforms, and often depend on remote services for monitoring, maintenance, or software updates. A control set that includes device identity and certificate-backed trust is the difference between a device that can be enrolled securely and one that is easy to spoof or impersonate. See NHIMG’s Device and IoT Identity Guide for the identity side of that trust model.
Cryptography also protects integrity, not just secrecy. In medical environments, an attacker does not need to read patient data to cause harm; changing a dosage setting, replacing software, or tampering with a command stream can be enough. Protecting data at rest, data in transit, and signed software paths helps keep the device operating as intended, even when the surrounding network is noisy, shared, or partially untrusted.
Why this is different from ordinary endpoint security
Connected medical devices have a smaller margin for error than general-purpose IT systems. Many are safety-relevant, long-lived, and difficult to patch without operational disruption. That makes cryptographic assurance more than a “best practice,” because it is often the only scalable way to validate device origin, software provenance, and update integrity across a mixed fleet.
The trust problem is also broader than the device itself. In healthcare, a single device may interact with shared workstations, clinical identity systems, remote support tools, and third-party service workflows. If those trust relationships are weak, attackers can abuse the legitimate update or management path instead of trying to break the device directly. NHIMG’s Healthcare Identity Security Guide is useful here because it ties medical device security to the surrounding clinical access environment.
Strong cryptographic controls reduce the chance that a counterfeit device, a tampered configuration package, or a stolen secret can be used as a foothold. They also help preserve provenance across the device lifecycle, which is important when devices move between environments, vendors, service providers, and clinical departments.
What strong cryptographic controls should actually achieve
For this class of system, the goal is not “use encryption somewhere.” The control objective is to create verifiable trust boundaries. A well-designed deployment should let you answer four questions with confidence: is this the right device, is this the genuine software, is the data protected in transit and at rest, and can the trust material be rotated or revoked when something changes?
- Device authentication should rely on unique, device-specific credentials, not shared defaults.
- Firmware and update paths should be signed so that unauthorized code cannot be installed quietly.
- Stored secrets, certificates, and keys should be protected so compromise of one layer does not expose the whole fleet.
- Trust material should support renewal and revocation, because unmanaged long-lived credentials create lingering exposure.
That control set aligns with standard security control families for identification, authentication, system integrity, and cryptographic protection. It is also where connected devices most often fail in practice: weak onboarding, hard-coded secrets, poor certificate lifecycle management, and inadequate signing enforcement.
Risk and Threat Considerations
Weak cryptographic controls in connected medical devices can turn routine connectivity into a safety and security exposure. If device identity is spoofable, update trust is weak, or secrets are reused across fleets, an attacker can impersonate a legitimate device, push tampered software, or interfere with data flows without needing direct physical access.
Failure mechanism: Attackers or insiders exploit weak onboarding, exposed secrets, unsigned updates, or poor certificate handling to bypass trust checks and introduce malicious or altered device behaviour.
Impact: The result can be device compromise, corrupted telemetry, unauthorised configuration changes, interrupted clinical workflows, and, in the worst case, patient harm or broader compromise of connected systems.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-9 — Service Identification and Authentication | Connected devices and update services need machine-to-machine trust. |
| IA-5 — Authenticator Management | Device certificates and secrets need controlled rotation and revocation. | |
| SI-7 — Software, Firmware, and Information Integrity | Signed firmware and configuration updates protect device integrity. | |
| Recommendation — Use IA-9 to require strong device and service authentication for connected medical device communications. Use IA-5 to manage device credentials, renewal, and revocation across the fleet. Use SI-7 to verify signed software and block unauthorised firmware or configuration changes. | ||
| ISO/IEC 27001:2022 | A.8.24 — Use of cryptography | The question is fundamentally about cryptographic protection of device data and trust. |
| A.5.17 — Authentication information | Device secrets and certificates must be protected across their lifecycle. | |
| Recommendation — Apply A.8.24 to protect device data and trust boundaries with appropriate cryptographic controls. Apply A.5.17 to secure device credentials, certificates, and other authentication material. | ||
| CIS Controls v8 | CIS-3 — Data Protection | Connected medical devices must protect sensitive data in transit and at rest. |
| CIS-6 — Access Control Management | Cryptographic trust determines which devices and updates are allowed to connect. | |
| Recommendation — Use CIS-3 to encrypt sensitive device data and protect it throughout transmission and storage. Use CIS-6 to restrict device access paths and enforce trusted authentication for connected systems. | ||
Practitioner Guidance
What to verify: Start by checking whether every device has unique identity material, whether firmware and configuration updates are cryptographically signed, and whether key rotation and revocation are operationally possible. If any of those answers is “no,” treat the device as relying on partial trust rather than strong trust.
What practitioners underestimate: The hardest part is usually not encryption itself, but lifecycle control. Keys, certificates, and signed-update paths have to survive onboarding, maintenance, replacement, and decommissioning without falling back to shared secrets or manual exceptions.
Practitioner takeaway: In connected medical devices, cryptography is valuable because it creates enforceable trust, but it only delivers that value when identity, update integrity, and secret lifecycle are managed together rather than as separate controls.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 27, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org